超声测量肱动脉反应性充血在重症患者中的观察性研究
该研究为病例对照联合前瞻性队列研究,在单中心纳入150例重症患者和44例无急性疾病对照者,用超声测量肱动脉反应性充血(RH,缺血前后肱动脉速度-时间积分百分比变化)。重症患者RH较对照者受损(194% vs 369%,p<0.001),脓毒症与非脓毒症重症患者相似(196% vs 199%,p=0.88)。医院死亡者RH显著低于存活者(144% vs 204%,p=0.003),多变量分析示RH每增加一个对数单位医院死亡OR=0.26(95%CI 0.08-0.83,p=0.02)。存活者3-5天后RH改善(204% vs 239%,p=0.02),死亡者无变化。
要点
- 重症患者肱动脉反应性充血(RH)较无急性疾病对照者受损:194%(95%CI 179-210) vs 369%(95%CI 314-433)%,p<0.001。
- 脓毒症与非脓毒症重症患者RH相似:196%(95%CI 177-217) vs 199%(95%CI 170-233),p=0.88。
- 医院死亡者RH显著低于存活者:144%(95%CI 120-173) vs 204%(95%CI 187-222),p=0.003。
- 校正年龄和合并症后,RH每增加一个对数单位,医院死亡OR=0.26(95%CI 0.08-0.83,p=0.02)。
- 存活者3-5天后RH改善(n=63,204% vs 239%,p=0.02),死亡者无变化(n=11,133% vs 128%)。
适用人群与场景
- 150例重症患者(单中心学术医疗中心)与44例无急性疾病对照者;重症患者中比较脓毒症与非脓毒症、医院存活者与死亡者。
- 子样本在3-5天后重复测量:存活者63例,死亡者11例。
研究设计与关键结果
- 研究类型:病例对照联合前瞻性队列研究;单中心;150例重症患者和44例无急性疾病对照者。
- RH计算为缺血前后肱动脉速度-时间积分百分比变化(多普勒超声测量)。
- 重症患者RH较对照者受损:194%(95%CI 179-210) vs 369%(95%CI 314-433)%,p<0.001。
- 脓毒症与非脓毒症重症患者RH相似:196%(95%CI 177-217) vs 199%(95%CI 170-233),p=0.88。
- 医院死亡者RH显著低于存活者:144%(95%CI 120-173) vs 204%(95%CI 187-222),p=0.003。
- 多变量分析:RH每增加一个对数单位,医院死亡OR=0.26(95%CI 0.08-0.83,p=0.02),校正年龄和合并症后仍独立相关。
- 存活者3-5天后RH改善:n=63,204%(95%CI 180-232) vs 239%(95%CI 208-275),p=0.02;死亡者无变化:n=11,133%(95%CI 107-165) vs 128%(95%CI 75-220)。
证据类型、等级与局限
- 证据类型:观察性研究(病例对照联合前瞻性队列)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在无明确脓毒症的重症患者中,肱动脉反应性充血可能有助于识别医院死亡高危者:死亡者RH低于存活者,且校正年龄和合并症后与医院死亡独立相关。
- 脓毒症与非脓毒症重症患者RH相似,提示该指标在重症患者中不限于脓毒症人群。
- 存活者3-5天后RH改善而死亡者无变化,提示动态监测RH可能提供预后信息。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Ultrasound-measured brachial artery reactive hyperemia (RH) is independently predictive of hospital mortality in critically ill patients with sepsis. Its association with mortality is uncertain in critically ill patients in general.
METHODS: This was a combined case-control and prospective cohort study. Ultrasound was used to measure brachial artery reactive hyperemia in 150 critically ill patients at a single academic medical center and in 44 control subjects without acute illness. Measurements were compared in cases versus controls, septic vs. non-septic critically ill patients, and hospital survivors vs. non-survivors. Follow-up measurements were obtained 3-5 days later in a sub-sample of patients.
RESULTS: RH was calculated as the percent change in pre- vs. post-ischemic brachial artery velocity-time integral measured by Doppler ultrasound. RH was impaired in critically ill compared to control subjects (194 [179-210] vs. 369 [314-433]%, p < 0.001; results expressed as mean [95% confidence interval]) but similar in septic compared to non-septic patients (196 [177-217] vs. 199 [170-233], p = 0.88). RH was significantly lower in hospital non-survivors compared to survivors (144 [120-173] vs. 204 [187-222], p = 0.003). Multivariable analysis showed that the difference between survivors and non-survivors was not confounded by age or comorbidities (odds ratio for hospital death = 0.26 per log unit rise in RH, 95% confidence interval = 0.08-0.83, p = 0.02). The magnitude of RH improved over 3-5 days in hospital survivors (n = 63, 204 [180-232] vs. 239 [208-275], p = 0.02), but did not change in non-survivors (n = 11, 133 [107-165] vs. 128 [75-220].
CONCLUSIONS: Reactive hyperemia of the brachial artery is impaired in undifferentiated critically ill patients, lower in non-survivors compared to survivors, and independently associated with hospital mortality. Brachial artery reactive hyperemia improves significantly over time in survivors but not in non-survivors.
参考来源
- Storms CR, Bice T, Zhang J, et al. Ultrasound-measured brachial artery reactive hyperemia in critically ill patients: an observational study. Crit Care. 2025. PMID: 40999434. doi:10.1186/s13054-025-05646-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。